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Objectives. This study was designed to investigate the associa- 
tion between wall motion abnormalities and the occurrence of 
ischemic mitral regurgitation in patients with a first inferior or 
posterior myocardial infarction and to reassess the role of throm- 
bolytic treatment in these patients. 
Background. We previously demonstrated that thrombolytic 
therapy reduces the incidence of significant mitral regurgitation 
in patients with a first inferior myocardial infarction, but the 
mechanisms responsible for this decrease were not clear. 
Methods. Wall motion score on two-dimensional echocardiog- 
raphy (16 segments) and mitral regurgitation grade (0 to 3) on 
Doppler color flow imaging were assessed in 95 patients (in 47 
after thrombolysis) at 24 h, 7 to 10 days and 1 month after 
myocardial infarction. Significant mitral regurgitation was de- 
fined as moderate or severe (grade 2 or 3). 
Results. Multivariate analysis revealed that the presence of an 
advanced wall motion abnormality of the posterobasal segment of 
the left ventricle was the most significant independent variable 
associated with significant mitral regurgitation: odds ratio (OR) 
15.0, 90% confidence interval (CI) 1.4 to 165.6 at 24 h; OR 2.8, CI 
0.9 to 9.3 at 7 to 10 days; OR 4.2, CI 1.2 to 11.4 at 1 month. 
Thrombolysis reduced the prevalence of advanced wall motion 
abnormalities in the posterobasal segment at 24 h (55% vs. 75%, 
OR 0.5, CI 0.2 to 0.99), 7 to 10 days (44% vs. 73%, OR 0.3, CI 0.1 
to 0.7) and 1 month (36% vs. 56% OR 0.4, CI 0.2 to 0.9). 
Conclusions. There is a strong association between advanced 
wall motion abnormalities in the posterobasal segment and 
significant mitral regurgitation. In this study group, thrombolysis 
reduced the prevalence of advanced wall motion abnormalities in 
the posterobasal segment and thereby reduced the incidence of 
significant mitral regurgitation. 
(J Am Coll Cardiol 1995;25:1558-63) 
New mitral regurgitation i acute myocardial infarction, de- 
fined as valve incompetence with no primary leaflet or chordal 
abnormalities, i  associated with the development of hemody- 
namic deterioration a d increased mortality (1-7). This disor- 
der is a relatively common complication ofacute ischemia nd 
frequently occurs in patients with inferior or posterior myocar- 
dial infarction (4,5,8). Recent reports (3-5,9-11) suggest hat 
the incidence of ischemic mitral regurgitation is 9% to 56%. 
Ischemic mitral regurgitation has traditionally been ascribed to 
"papillary muscle dysfunction." Originally, Burch et al. (12) 
proposed that papillary muscle dysfunction could be due to 
either mitral valve prolapse or incomplete mitral valve closure. 
Subsequent s udies uggested additional mechanisms for mi- 
tral valve incompetence in acute myocardial infarction: mitral 
annulus dilation (5,13) and left ventricular dilation (5,11,14) or 
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dysfunction (5,10). The role of regional myocardial dysfunction 
in the development of ischemic mitral regurgitation has been 
controversial (15-20) and has not yet been thoroughly eluci- 
dated. 
We (9) previously demonstrated that thrombolytic therapy 
reduces the incidence of significant mitral regurgitation i
patients with a first inferior myocardial infarction, but the 
mechanisms responsible for this decrease were not clear. 
The current series of analyses were undertaken to investi- 
gate the possible association between segmental wall motion 
abnormalities and the occurrence of ischemic mitral regurgi- 
tation in patients with a first inferior or posterior myocardial 
infarction and to reassess the role of thrombolytic treatment in
these patients. 
Methods  
Study patients. During the 18-month study period from 
December 5,1989 to June 4, 1991, 462 patients were admitted 
to the intensive coronary care unit at Sheba Medical Center 
with a documented myocardial infarction. As indicated in our 
previous communication (9), our study patients were patients 
<76 years of age with acute inferior, inferoposterior, infero- 
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Figure 1. Diagrammatic representation of 16-segment regional wall 
motion analysis n the standard two-dimensional echocardiographic 
views. 1 and 2 = anteroseptal; 3 = lateral; 4 = posterobasal; 5 = 
inferobasal; 6 = inferoseptal; 7 and 8 = anteroseptal; 9 =lateral; 10 = 
posterior; 11 = inferior; 12 = inferoseptal; 13 = anterior; 14 = lateral; 
15 = inferior; 16 = septal. Modified from the recommendations of the 
American Society of Echocardiography reported by Schiller et al. (24). 
lateral or extensive posterior (inferoposterolateral) wallmyo- 
cardial infarction. 
Definitions of inferior, posterior or right ventricular myo- 
cardial infarction as well as the thrombolytic protocol and the 
noninvasive criteria for reperfusion are based on accepted 
criteria (4,9,21,22). Exclusion criteria were 1) a history of prior 
myocardial infarction; 2) the presence of rheumatic heart 
disease or heart failure or a history of cardiac surgery or 
percutaneous transluminal coronary angioplasty; 3)a history of 
organic mitral valve disease; 4) inadequate echocardiographic 
images. 
Echocardiography. Each patient underwent three echocar- 
diographic examinations: 1)within 24 h after the onset of chest 
pain; 2) at 7 to 10 days after infarction, and 3) at 1 month (28 
to 30 days) after infarction (9). 
All two-dimensional echocardiographic studies included 
pulsed Doppler and color flow imaging. Severity of mitral 
regurgitation was graded according to the method of Helmcke 
et al. (23): No regurgitation was classified as grade 0; a mitral 
regurgitation jet occupying 5% to 19%, 20% to 39% and 
>-40% of the left atrial area represented, respectively, mild 
(grade 1), moderate (grade 2) and severe (grade 3) mitral 
regurgitation. 
To assess regional wall motion, one of us (A.T.) retrospec- 
tively reviewed all echocardiograms in blinded manner without 
knowledge of the interpretation of the mitral regurgitation 
grading. The left ventricle was divided into 16 segments 
according to the recommendation of the American Society of 
Echocardiography (24) with slight modification i terminology 
and the addition of an apical ong-axis view (Fig. 1). For each 
segment, wall motion was graded as follows: normal = 0, 
hypokinetic = 1, akinetic = 2, and dyskinetic = 3. When the 
wall motion scores obtained from the long- and the short-axis 
views differed, we always elected the score with more signifi- 
cant regional abnormalities. 
To assess interobserver and intraobserver variability, 40 ran- 
domly chosen echocardiograms (640 segments) were analyzed 
several weeks later by two observers (Z.V. and A.T.), one of 
whom had scored those echocardiograms earlier. On a seg- 
ment by segment basis, these reproducibility studies howed a
concordance of 93% in the assessment of wall motion score 
between two observers, and of 95% between the two studies 
scored by the same observer. 
End points. The primary end points of this study were the 
development of advanced wall motion abnormalities: akinesia 
or dyskinesia, nd significant mitral regurgitation (grade 2 or 
3). Secondary end points were the presence of all types of wall 
motion abnormalities (hypokinesia, akinesia or dyskinesia), 
development of mitral regurgitation of any grade and in- 
hospital and follow-up events. 
Statistical methods. As a measure of association between 
the levels of segmental wall motion abnormalities and grade of 
mitral regurgitation severity, the Spearman rank correlation 
coefficient was used. Univariate analysis methods included the 
chi-square test for categoric variables. To estimate the odds 
ratio for the tables with zero entries, 0.5 was added to each cell. 
In this case the estimation ofconfidence interval was based on 
the log odds ratio. Multivariate analysis was performed by 
using a logistic regression model with a stepwise selection of 
factors. 
The model for prediction of mitral regurgitation i cluded 
age, gender, congestive heart failure, administration f throm- 
bolytic therapy and the development of advanced wall motion 
abnormalities (akinesia/dyskinesia); thrombolytic therapy and 
advanced wall motion abnormalities were forced into the 
model. The model with wall motion abnormalities as the 
dependent variable included age, gender, congestive heart 
failure and administration f thrombolytic therapy. Odds ratios 
attributable to the factors were estimated from coefficients of 
logistic regression. 
The statistical analysis ystem (SAS) software was used, 
especially FREC, CORR and LOGISTIC procedures (25). 
Results 
Ninety-five patients met the criteria for eligibility in the 
study. At study 2 (7 to 10 days), a technically adequate 
echocardiogram was obtained in 89 patients. Three patients 
died after the second examination period; two patients missed 
the second study, but one of them was included in the last 
follow-up. Thus, at the 1 month study, echocardiograms of 85 
patients were analyzed. 
Clinical characteristics. Table 1 presents the baseline clin- 
ical characteristics of the 95 patients with a first inferior 
myocardial infarction included in the study. The majority 
(78%) were male. Electrocardiographic criteria for posterior 
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Table 1. Clinical Characteristics of the 95 Patients Included in 
the Study 
Age (yr) 60 _+ 11 
Female 22 (23%) 
Diabetes mellitus 13 (14%) 
Hypertension 21 (22%) 
Posterior MI 55 (58%) 
Right ventricular MI 23 (24%) 
LVEF (n = 70) (%) 52.5 _+ 8% 
Complete AV block 19 (20%) 
Arrhythmias 32 (34%) 
Post MI ischemia 40 (42%) 
Heart failure 14 (15%) 
Mortality 3 (3%) 
Revascularization (PTCA or CABG) 10 (10.5%) 
Thrombolytic reatment 47 (49.5%) 
Cardiac atheterization 20 (21%) 
Data are presented as number (%) of patients or mean value _+ SD. AV = 
atrioventricular; CABG = coronary artery bypass grafting; LVEF = left 
ventricular ejection fraction; MI = myocardial infarction; PTCA = percutaneous 
translumflaal coronary angioplasty. 
wall involvement were present in 58% of patients and for right 
ventricular involvement in 24%. Intravenous thrombolytic 
therapy was administered to 47 patients within 3.3 _+ 2.7 h 
(mean _ SD) after the onset of chest pain. Thirty-five patients 
(74%) were judged to have successful reperfusion by clinical 
criteria. Forty-eight patients did not receive thrombolytic 
therapy because of contraindications to thrombolysis or late 
arrival (>6 h) after the onset of chest pain. Between the 
second and third follow-up examinations, 10 patients (10.5%) 
underwent revascularization (percutaneous transluminal coro- 
nary angioplasty in 8 patients, coronary artery bypass grafting 
in 2); 5 of the 10 patients had received thrombolytic therapy. 
Univariate Spearman correlation analysis. Significant cor- 
relation coefficients (r > 0.2) between echocardiographic 
segmental wall motion abnormality score and mitral regurgi- 
tation grade were present only for the posterobasal, infero- 
basal, midposterior, midinferior and posterotateral regions 
(Table 2). The correlation between mitral regurgitation grade 
and wall motion abnormality score of the posterobasal seg- 
ment was the most significant of these correlations at all study 
periods after myocardial infarction. Because the correlation 
coefficients between the five segments themselves was very 
high (r = 0.56 to 0.93), only the posterobasal segment wall 
motion score was included in the multivariate logistic analyses. 
Association between advanced wall motion abnormalities of 
the posterobasal segment and the incidence of mitral regurgi- 
tation. Table 3 shows the correlation between the incidence 
and severity of mitral regurgitation and the presence or 
absence of advanced wall motion abnormalities (akinesia/ 
dyskinesia) of the posterobasal segment. Such abnormalities 
were present in 62 patients (65%) at 24 h, in 53 patients (60%) 
at 7 to 10 days and in 39 patients (46%) at 1 month. The 
presence of mitral regurgitation of any grade was correlated 
with these advanced abnormalities. 
Clinical significance of advanced wall motion abnormali- 
ties of the posterobasal segment as a predictor of mitral 
regurgitation. Stepwise logistic regression analysis disclosed 
that the presence of advanced wall motion abnormalities of the 
posterobasal segment was a strong, independent and signifi- 
cant predictor associated with the presence of any grade of 
mitral regurgitation at any study period (Table 4). The associ- 
ation between these advanced abnormalities and the presence 
of significant mitral regurgitation at 7 to 10 days was of 
borderline significance (OR 2.8, 90%, CI 0.9 to 9.3). An 
especially strong association was noted between these abnor- 
malities and the presence of significant mitral regurgitation 
(grade 2 or 3) at 24 h: All the patients with significant mitral 
regurgitation had advanced wall motion abnormalities of the 
posterobasal segment. 
Influence of posterobasal segment dyskinesia on the prev- 
alence of significant mitral regurgitation. At 24 h, there were 
nine patients with posterobasal segment dyskinesia, three 
(33%) of whom had significant mitral regurgitation. At 7 to 10 
days, seven patients had posterobasal segment dyskinesia, five 
(71%) of whom had significant mitral regurgitation; and of the 
eight patients with posterobasal segment dyskinesia at 1 
month, 7 (87%) had significant mitral regurgitation (Fig. 2). 
Severe mitral regurgitation (grade 3) was found only in one 
patient at 24 h, in five patients at 7 to 10 days and in four 
patients at 1 month. 
Influence of thrombolysis on the prevalence of posterobasal 
advanced wall motion abnormalities in a first inferior myo- 
cardial infarction (Table 5). Patients receiving thrombolytic 
therapy had a reduced prevalence of advanced wall motion 
abnormalities (akinesia/dyskinesia) n the posterobasal seg- 
ment at 24 h (55% vs. 75%, OR 0.5, 90% CI 0.2 to 0.99), at 7 
to 10 days (44% vs. 73%, OR 0.3, 90% CI 0.1 to 0.7) and at 1 
month (36% vs. 56%, OR 0.4, 90% CI 0.2 to 0.9). 
Effect of revascularization procedures on the presence of 
advanced wall motion abnormalities in the posterobasal seg- 
ment and the severity of mitral regurgitation. Between the 
studies at 7 to 10 days and 1 month, eight patients underwent 
angioplasty (four patients had received thrombolysis) and two 
underwent coronary artery bypass grafting (one of whom had 
received thrombolysis). Angioplasty was performed in the left 
anterior descending coronary artery in one patient, in the left 
circumflex coronary artery in four patients and in the right 
coronary artery in three. Six of these eight patients had 
Table 2. Significant Spearman Correlation Coefficients (r) Between 
the Grade of Mitral Regurgitation and Segmental Wall Motion 
Abnormalities in the Study Patients 
Wall Motion 24 h 7-10 days 1 month 
Abnormality (n = 95) (n = 89) (n = 85) 
Posterobasal 0.306, p= 0.003 0.342, p = 0.001 0.373, p= 0.0004 
Inferobasal 0.24, p = 0.02 0.285, p= 0.007 0.297, p = 0.006 
Midinferior 0.27, p = 0.07 0.255, p= 0.02 NS 
Midposterior NS 0.268, p= 0.01 0.355, p= 0.0008 
Posterolateral NS NS 0.330, p= 0.002 
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Table 3. Association Between Posterobasal Advanced Wall Motion Abnormalities and the Incidence and Severity of Mitral Regurgitation 
Mitral Regurgitation 
None Mild Moderate Severe Total 
All Pts (grade 0) (grade 1) (grade 2) (grade 3) MR 
At 24 h 
With AWMA "62 (100%) 37 (59.7%) 14 (22.6%) 10 (16.1%) 1 (1.6%) 25 (40.3%) 
Without AWMA 33 (100%) 26 (78.8%) 7 (21.2%) 0 (0%) 0 (0%) 7 (21.2%) 
Total 95 (100%) 63 (66.3%) 21 (22.l%) l0 (10.5%) 1 (1.1%) 32 (33.7%) 
At 7-10 days 
With AWMA 53 (100%) 24 (45.3%) 14 (26.4%) 10 (18.9%) 5 (9.4%) 29 (54.7%) 
Without AWMA 36 (100%) 26 (72.2%) 6 (16.7%) 4 (11.1%) 0 (0%) 10 (27.8%) 
Total 89 (100%) 50 (56.2%) 20 (22.5%) 14 (15.7%) 5 (5.6%) 39 (43.8%) 
At 1 month 
With AWMA 39 (100%) 20 (51.3%) 10 (25.6%) 3 (7.7%) 6 (15.4%) 19 (48.7%) 
Without AWMA 46 (100%) 34 (73.9%) 8 (17.4%) 4 (8.7%) 0 (0%) 12 (26.1%) 
Total 85 (100%) 54 (63.5%) 18 (21.2%) 7 (8.2%) 6 (7.l%) 31 (36.5%) 
Data are presented asnumber (%) of patients. AWMA advanced wall motion abnormalities (akinesia/dyskinesia) of the posterobasal egment; MR - mitral 
regurgitation; Pts = patients. 
advanced wall motion abnormalities in a posterobasal segment 
and four had mitral regurgitation. Successful revascularization 
markedly improved posterobasal wall motion in five patients 
and reduced mitral regurgitation i  three (from moderate to 
mild). The only patient with postinfarction angina in whom 
coronary angioplasty did not improve posterobasal wall motion 
or reduce the severity of mitral regurgitation had total occlu- 
sion of the left circumflex coronary artery and dilation was 
performed on the lesion in the left anterior descending artery 
(not the infarct-related vessel). 
Discussion 
We (9) have previously demonstrated that thrombolytic 
therapy during a first inferior myocardial infarction is associ- 
ated with a reduced incidence and severity of ischemic mitral 
regurgitation. However, the exact mechanisms of the develop- 
ment of mitral regurgitation in acute inferior myocardial 
Table 4. Odds Ratios of Posterobasal Advanced Wall Motion 
Abnormalities for Development ofMitral Regurgitation i  a First 
Inferior Myocardial Infarction 
Odds 90% Confidence 
Ratio Interval 
At 24 h 
MR of any grade* 2.3 1.0-5.3 
Significant MRt 15.0 1.4-165.6 
At %10 days 
MR of any grade* 3.2 1.4-7.2 
Significant MR* 2.8 0.9-9.3 
At 1 month 
MR of any grade* 4.0 1.6-9.9 
Significant MR* 4.2 1.2-ti.4 
*Odds ratio adjusted for use of thrombolytic reatment, patient age and 
gender and presence ofheart failure, tUnadjusted o ds ratio (all patients with 
significant mitral regurgitation had advanced wall motion abnormalities). MR = 
mitral regurgitation. 
infarction and its decreased severity after thrombolysis are not 
clear. The main finding of the present study is the strong 
association between advanced wall motion abnormalities 
(akinesia/dyskinesia) n the posterobasal segment of the left 
~,entricle and the development of significant mitral regurgita- 
tion. The use of thrombolytic therapy during a first inferior 
myocardial infarction considerably reduced the incidence of 
these advanced abnormalities and, as a consequence, the 
incidence of significant mitral regurgitation. 
Ischemic mitral regurgitation is a complex phenomenon 
(5,8,18) and has often been attributed to papillary muscle 
dysfunction leading to rnitral leaflet eversion or prolapse into 
the left atrium (12,13,19,25-27). 
Subsequent studies suggested additional mechanisms for 
mitral regurgitation after myocardial infarction--in particular, 
left ventricular and mitral annulus dilation in anterior (but not 
in inferior) myocardial infarction (5,10,14). In inferior myocar- 
dial infarction an alternative mechanism--namely, d skinesia 
of the corresponding ventricular wall--was suggested 
(11,18,20). Moreover, several studies (15-17) suggested that 
Figure 2. Influence of posterobasal segment dyskinesia on the preva- 
lence of significant mitral regurgitation (MR). Data are presented as 
percent of patients. The number of patients with (solid line)/without 
(dotted line) posterobasal segment dyskinesia was 9/86 at T1 (24 h), 
7/82 at T2 (7 to 10 days) and 8/77 at T3 (1 month). 
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Table 5. Influence of Thrombolysis on the Prevalence ofthe Posterobasal Advanced Wall Motion 
Abnormalities in a First Inferior Myocardial Infarction 
With With 
Total Group Hypokinesia Akinesia/Dyskinesia 
At24h 
Total group 95 
With thrombolysis 47 
Without hrombolysis 48 
OR (CI), p value 
At 7 to 10 h 
Total group 89 
With thrombolysis 41" 
Without hrombolysis 48 
OR (CI), p value 
At 1 month 
Total group 85 
With thrombolysis 42 
Without hrombolysis 43 
OR (CI), p value 
33 (35%) 62 (65%) 
21 (45%) 26 (55%) 
12 (25%) 36 (75%) 
0.5 (0.2-0.99), p = 0.04 
36 (40%) 53 (60%) 
23 (56%) 18 (44%) 
13 (27%) 35 (73%) 
0.3 (0.1-0.7), p = 0.005 
46 (54%) 39 (46%) 
27 (64%) 15 (36%) 
29 (44%) 24 (56%) 
0.4 (0.2-0.9)~ p = 0.06 
Data are presented as number (%) of patients, *One patient receiving thrombolytic treatment failed to participate 
in the study at 7 to 10 days, CI = 90% confidence interval; OR = odds ratio adjusted for patient age and gender and 
presence of heart failure. 
advanced wall motion abnormalities in areas of the myocar- 
dium supporting the papillary muscles (leading to the displace- 
ment of papillary muscles and retraction of the mitral leaflets) 
appear to be a sufficient condition for the development of 
ischemic mitral regurgitation even without ischemia of the 
papillary muscle. 
The present study demonstrated a significant correlation 
between the grade of mitral regurgitation and wall motion 
abnormality score for posterobasal, inferobasal, midposterior, 
midinferior (area of posterior papillary muscle) and postero- 
lateral regions. The most significant correlations at any study 
period were obtained for mitral regurgitation grade and pos- 
terobasal segmental wall motion score by both univariate and 
multivariate logistic analysis. 
Severe mitral regurgitation (grade 3) was found in only one 
patient at 24 h, but it was present in five patients at 7 to 10 days, 
one of whom later died, thus leaving four of these patients at 
the 1-month study. In all cases evere mitral regurgitation was 
associated with dyskinesia of the posterobasal segment of the 
left ventricle. When severe mitral regurgitation developed, it
did not resolve spontaneously. 
It is now well established (28-30) that thrombolytic therapy 
administered soon after acute myocardial infarction preserves 
left ventricular function and improves regional wall motion. 
Although this treatment has been widely accepted in patients 
with anterior wall myocardial infarction, its value in patients 
with inferior or posterior wall myocardial infarction has been 
controversial (31-33). Our data show that thrombolysis n a 
first inferior myocardial infarction preserves posterobasal left 
ventricular function and significantly decreases the number of 
patients with advanced wall motion abnormalities (akinesia/ 
dyskinesia) in this region. 
There are sparse and discordant data regarding the effect of 
thrombolysis on the development of postinfarction mitral 
regurgitation. In accordance with preliminary reports from the 
Thrombolysis nMyocardial Infarction (TIMI) I trial (7), acute 
ischemic mitral regurgitation is independent ofcoronary artery 
patency before or after thrombolysis and cannot be success- 
fully treated by reperfusion of the infarct-related artery with 
late thrombolytic therapy. In contrast, several studies have 
demonstrated a beneficial effect of intracoronary (34) or 
intravenous (9) thrombolysis and emergency angioplasty on 
ischemic mitral regurgitation (35,36). 
In our study, the prevalence of postinfarction mitral regur- 
gitation was associated with advanced posterobasal wall mo- 
tion abnormalities in the total study group. However, there 
were fewer patients with posterobasal kinesia/dyskinesia in 
the group with than in the group without hrombolysis. There- 
fore, the incidence of mitral regurgitation was significantly 
lower among patients who received thrombolytic therapy. On 
the basis of these data, we suggest that successful rcperfusion 
after thrombolysis protects against advanced wall motion ab- 
normalities in the posterobasal left ventricular region (area of 
myocardium supporting the posteromedial papillary muscle) 
and thus reduces the incidence and severity of mitral regurgi- 
tation. 
Limitations of the study. The major limitation of our study 
is the lack of immediate coronary angiography in most pa- 
tients. This procedure would have helped to correlate the 
prevalence and severity of mitral regurgitation with the objec- 
tive proof of successful thrombolytic therapy, early patency of 
the infarct-related artery and possible value of its late sponta- 
neous reeanalization. Another shortcoming is the absence of 
data on left ventricular and mitral ring sizes. However, most of 
the previous tudies (10,14) demonstrated an association be- 
tween left ventricular or mitral annulus ize and mitral regur- 
gitation for anterior, but not for inferior, myocardial infarction. 
In the present study we used echocardiography to assess 
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regional eft ventricular function. The improved yield of two- 
dimensional echocardiography in quantifying regional wall 
motion abnormalities in comparison with that of contrast or 
radionuclide ventriculography, or both, has been widely dis- 
cussed and is now well established (28-30). 
Conclusions and clinical implications. This study demon- 
strated a strong association between advanced wall motion 
abnormalities (akinesia/dyskinesia) in the posterobasal seg- 
ment of the left ventricle and the development of significant 
postinfarction mitral regurgitation. Administration of throm- 
bolytic therapy during a first inferior myocardial infarction 
considerably reduced the incidence of advanced posterobasal 
segmental dysfunction and may protect against the develop- 
ment of significant mitral regurgitation. On the basis of these 
findings, we strongly support the use of thrombolytic therapy in 
• patients with a first inferior myocardial infarction, especially in 
those with advanced posterobasal wall motion abnormalities 
on echocardiography. 
We are indebted to Therry Katz for secretarial ssistance in the preparation of
this manuscript and to Semadar Truman, RN for dedicated assistance in the 
administration f this study. 
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